Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era.
Daisuke Katoh; Yotaro Ochi; Tomohiro Yabushita; Yuichiro Ono; Nobuhiro Hiramoto; Satoshi Yoshioka; Noboru Yonetani; Akiko Matsushita; Hisako Hashimoto; Shuichiro Kaji; Yukihiro Imai; Takayuki Ishikawa
Clinical lymphoma, myeloma & leukemia, 2017年12月, 査読有り